{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:37:10Z","timestamp":1784079430441,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:00:00Z","timestamp":1683331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:00:00Z","timestamp":1683331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA244360"],"award-info":[{"award-number":["R01CA244360"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1GM132142"],"award-info":[{"award-number":["RO1GM132142"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1245\/s10434-023-13587-0","type":"journal-article","created":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T20:01:14Z","timestamp":1683403274000},"page":"5132-5141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Novel Assessment of Metabolic Pathways in Peritoneal Metastases from Low-Grade Appendiceal Mucinous Neoplasms"],"prefix":"10.1245","volume":"30","author":[{"given":"Eric A.","family":"Hanse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"Tifrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheswari","family":"Senthil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex C.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0226-5005","authenticated-orcid":false,"given":"Oliver S.","family":"Eng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,6]]},"reference":[{"issue":"3","key":"13587_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","volume":"30","author":"J Franko","year":"2012","unstructured":"Franko J, Shi Q, Goldman CD, et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012;30(3):263\u20137.","journal-title":"J Clin Oncol."},{"issue":"2","key":"13587_CR2","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jpainsymman.2010.05.007","volume":"41","author":"A Chakraborty","year":"2011","unstructured":"Chakraborty A, Selby D, Gardiner K, Myers J, Moravan V, Wright F. Malignant bowel obstruction: natural history of a heterogeneous patient population followed prospectively over two years. J Pain Symptom Manage. 2011;41(2):412\u201320.","journal-title":"J Pain Symptom Manage."},{"issue":"3","key":"13587_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1708618","volume":"378","author":"WJ van Driel","year":"2018","unstructured":"van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378(3):230\u201340.","journal-title":"N Engl J Med."},{"issue":"2","key":"13587_CR4","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Quenet","year":"2021","unstructured":"Quenet F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):256\u201366.","journal-title":"Lancet Oncol."},{"issue":"20","key":"13587_CR5","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30(20):2449\u201356.","journal-title":"J Clin Oncol."},{"issue":"2","key":"13587_CR6","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1245\/s10434-007-9691-2","volume":"15","author":"D Baratti","year":"2008","unstructured":"Baratti D, Kusamura S, Nonaka D, et al. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2008;15(2):526\u201334.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"13587_CR7","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/cncr.24715","volume":"116","author":"JF Shapiro","year":"2010","unstructured":"Shapiro JF, Chase JL, Wolff RA, et al. Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experience. Cancer. 2010;116(2):316\u201322.","journal-title":"Cancer."},{"issue":"1","key":"13587_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov."},{"issue":"5","key":"13587_CR9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell."},{"issue":"21","key":"13587_CR10","doi-asserted-by":"publisher","first-page":"6479","DOI":"10.1158\/1078-0432.CCR-09-0889","volume":"15","author":"CV Dang","year":"2009","unstructured":"Dang CV, Le A, Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res. 2009;15(21):6479\u201383.","journal-title":"Clin Cancer Res."},{"issue":"9","key":"13587_CR11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrd3504","volume":"10","author":"MG Vander Heiden","year":"2011","unstructured":"Vander Heiden MG. Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov. 2011;10(9):671\u201384.","journal-title":"Nat Rev Drug Discov."},{"issue":"10","key":"13587_CR12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Martinez-Reyes","year":"2021","unstructured":"Martinez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer. 2021;21(10):669\u201380.","journal-title":"Nat Rev Cancer."},{"key":"13587_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.962928","volume":"12","author":"EA Hanse","year":"2022","unstructured":"Hanse EA, Kong M. A happy cell stays home: when metabolic stress creates epigenetic advantages in the tumor microenvironment. Front Oncol. 2022;12:962928.","journal-title":"Front Oncol."},{"issue":"1","key":"13587_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12943-022-01703-9","volume":"22","author":"Y Mo","year":"2023","unstructured":"Mo Y, Leung LL, Mak CSL, et al. Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis. Mol Cancer. 2023;22(1):4.","journal-title":"Mol Cancer."},{"issue":"8","key":"13587_CR15","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1158\/0008-5472.CAN-19-1999","volume":"80","author":"A Mukherjee","year":"2020","unstructured":"Mukherjee A, Chiang CY, Daifotis HA, et al. Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance. Cancer Res. 2020;80(8):1748\u201361.","journal-title":"Cancer Res."},{"issue":"1","key":"13587_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12967-022-03763-3","volume":"20","author":"Q Yang","year":"2022","unstructured":"Yang Q, Bae G, Nadiradze G, et al. Acidic ascites inhibits ovarian cancer cell proliferation and correlates with the metabolomic, lipidomic and inflammatory phenotype of human patients. J Transl Med. 2022;20(1):581.","journal-title":"J Transl Med."},{"key":"13587_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/978-1-61737-985-7_11","volume":"708","author":"A Garcia","year":"2011","unstructured":"Garcia A, Barbas C. Gas chromatography-mass spectrometry (GC-MS)-based metabolomics. Methods Mol Biol. 2011;708:191\u2013204.","journal-title":"Methods Mol Biol."},{"issue":"15","key":"13587_CR18","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114\u201320.","journal-title":"Bioinformatics."},{"issue":"1","key":"13587_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics."},{"issue":"7","key":"13587_CR20","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923\u201330.","journal-title":"Bioinformatics."},{"issue":"12","key":"13587_CR21","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol."},{"issue":"43","key":"13587_CR22","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"11","key":"13587_CR23","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res."},{"issue":"6","key":"13587_CR24","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1073\/pnas.71.6.2505","volume":"71","author":"VP Wellner","year":"1974","unstructured":"Wellner VP, Sekura R, Meister A, Larsson A. Glutathione synthetase deficiency, an inborn error of metabolism involving the gamma-glutamyl cycle in patients with 5-oxoprolinuria (pyroglutamic aciduria). Proc Natl Acad Sci U S A. 1974;71(6):2505\u20139.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"13587_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13054-019-2450-5","volume":"23","author":"Y Gamarra","year":"2019","unstructured":"Gamarra Y, Santiago FC, Molina-Lopez J, et al. Pyroglutamic acidosis by glutathione regeneration blockage in critical patients with septic shock. Crit Care. 2019;23(1):162.","journal-title":"Crit Care."},{"issue":"5","key":"13587_CR26","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1016\/j.bbagen.2012.09.008","volume":"1830","author":"SC Lu","year":"2013","unstructured":"Lu SC. Glutathione synthesis. Biochim Biophys Acta. 2013;1830(5):3143\u201353.","journal-title":"Biochim Biophys Acta."},{"issue":"7","key":"13587_CR27","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1083\/jcb.201804161","volume":"217","author":"A Bansal","year":"2018","unstructured":"Bansal A, Simon MC. Glutathione metabolism in cancer progression and treatment resistance. J Cell Biol. 2018;217(7):2291\u20138.","journal-title":"J Cell Biol."},{"issue":"1","key":"13587_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","volume":"14","author":"UE Martinez-Outschoorn","year":"2017","unstructured":"Martinez-Outschoorn UE, Peiris-Pages M, Pestell RG, Sotgia F, Lisanti MP. Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol. 2017;14(1):11\u201331.","journal-title":"Nat Rev Clin Oncol."},{"issue":"3","key":"13587_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW. The warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 2016;41(3):211\u20138.","journal-title":"Trends Biochem Sci."},{"issue":"3","key":"13587_CR30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41416-020-0898-3","volume":"123","author":"M Natsume","year":"2020","unstructured":"Natsume M, Shimura T, Iwasaki H, et al. Omental adipocytes promote peritoneal metastasis of gastric cancer through the CXCL2-VEGFA axis. Br J Cancer. 2020;123(3):459\u201370.","journal-title":"Br J Cancer."},{"issue":"4","key":"13587_CR31","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nrd.2016.233","volume":"16","author":"WJ Lesterhuis","year":"2017","unstructured":"Lesterhuis WJ, Bosco A, Millward MJ, Small M, Nowak AK, Lake RA. Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity. Nat Rev Drug Discov. 2017;16(4):264\u201372.","journal-title":"Nat Rev Drug Discov."},{"issue":"1","key":"13587_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/gutjnl-2018-318070","volume":"69","author":"R Wang","year":"2020","unstructured":"Wang R, Song S, Harada K, et al. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response. Gut. 2020;69(1):18\u201331.","journal-title":"Gut."},{"key":"13587_CR33","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.2147\/OTT.S245663","volume":"13","author":"G Pan","year":"2020","unstructured":"Pan G, Ma Y, Suo J, et al. Discovering biomarkers in peritoneal metastasis of gastric cancer by metabolomics. Onco Targets Ther. 2020;13:7199\u2013211.","journal-title":"Onco Targets Ther."},{"issue":"1","key":"13587_CR34","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3390\/cancers3011285","volume":"3","author":"AL Ortega","year":"2011","unstructured":"Ortega AL, Mena S, Estrela JM. Glutathione in cancer cell death. Cancers (Basel). 2011;3(1):1285\u2013310.","journal-title":"Cancers (Basel)."},{"key":"13587_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.744992","volume":"9","author":"X Jiang","year":"2021","unstructured":"Jiang X, He Y, Shen Q, et al. RETSAT mutation selected for hypoxia adaptation inhibits tumor growth. Front Cell Dev Biol. 2021;9:744992.","journal-title":"Front Cell Dev Biol."},{"issue":"1","key":"13587_CR36","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13046-022-02490-3","volume":"41","author":"Q Tu","year":"2022","unstructured":"Tu Q, Liu X, Yao X, et al. RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res. 2022;41(1):274.","journal-title":"J Exp Clin Cancer Res."},{"issue":"9","key":"13587_CR37","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1007\/s00125-006-0335-z","volume":"49","author":"C Lagathu","year":"2006","unstructured":"Lagathu C, Yvan-Charvet L, Bastard JP, et al. Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Diabetologia. 2006;49(9):2162\u201373.","journal-title":"Diabetologia."},{"issue":"10","key":"13587_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078366","volume":"8","author":"V Andersen","year":"2013","unstructured":"Andersen V, Holst R, Kopp TI, Tjonneland A, Vogel U. Interactions between diet, lifestyle and IL10, IL1B, and PTGS2\/COX-2 gene polymorphisms in relation to risk of colorectal cancer in a prospective Danish case-cohort study. PLoS One. 2013;8(10):e78366.","journal-title":"PLoS One."},{"issue":"44","key":"13587_CR39","doi-asserted-by":"publisher","first-page":"72167","DOI":"10.18632\/oncotarget.12354","volume":"7","author":"V Gelfo","year":"2016","unstructured":"Gelfo V, Rodia MT, Pucci M, et al. A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors. Oncotarget. 2016;7(44):72167\u201383.","journal-title":"Oncotarget."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13587-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-13587-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13587-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T20:26:29Z","timestamp":1688502389000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-13587-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,6]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["13587"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-13587-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,6]]},"assertion":[{"value":"3 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Eric A. Hanse, Tianhong Wang, Delia Tifrea, Maheswari Senthil, Alex C. Kim, Mei Kong, and Oliver S. Eng have no relevant financial disclosures to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}